Baudax Bio
BXRX
$0.02180
Share price
7.39%
Change (1 day)
-97.01%
Change (1 year)
Categories
Operating Margin for Baudax Bio (BXRX)
Operating Margin as of May 2024 (TTM): -2,814.40%
According to Baudax Bio 's latest financial reports and stock price the company's current Operating Margin is -2,814.40%. At the end of 2021 the company had an Operating Margin of -1,830.46%.
Operating Margin history for Baudax Bio from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,830.46% | -88.14% |
| 2020 | -15,436.11% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.